A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Futibatinib | CAS 1448169-71-8 - Request Quote

Picture of Futibatinib
SZ CAT No:SZ-F097001
CAS No
1448169-71-8
Mol.F.
C22H22N6O3
Mol.Wt.
418.5
Inv. Status
Synthesis on demand
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Futibatinib is chemically (S)-1-(3-(4-Amino-3-((3,5-dimethoxyphenyl)ethynyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pyrrolidin-1-yl)prop-2-en-1-one. Futibatinib is supplied with detailed characterization data compliant with regulatory guideline. Futibatinib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Futibatinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1448169-71-8

Purchase 1448169-71-8

Order 1448169-71-8

Enquire 1448169-71-8

price of 1448169-71-8

1448169-71-8 Supplier

1448169-71-8 Manufacturer

1448169-71-8 Exporter

buy high quality Futibatinib

Purchase Futibatinib

Futibatinib suppliers

Futibatinib manufacturers

Futibatinib price

Order Futibatinib

Enquire Futibatinib

Futibatinib cost

Futibatinib Supplier

Futibatinib Distributor

Futibatinib for Method Validation

Futibatinib Reference Standard

Futibatinib for ANDA Filing

Futibatinib for Forced Degradation Studies

Futibatinib Identification Standards

Futibatinib for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,